Swedish women aged 20–24 on diabetes drugs: 9.1 per 1,000 in 2019, 26.4 in 2025 (+190%)

Women aged 20–24 in Sweden filling at least one diabetes prescription per year rose from 9.1 per 1,000 in 2019 to 26.4 in 2025, after a slow climb from 7.1 in 2010. Much of the rise since 2022 comes from GLP-1 drugs and tirzepatide, which are also prescribed for weight loss.